Population pharmacokinetics and effects of indinavir in HIV infected patients.

被引：0
|
作者：
Csajka, C
Marzolini, C
Fattinger, K
Decosterd, LA
Telenti, A
Biollaz, J
Buclin, T
机构：
[1] Univ Lausanne Hosp, Lausanne, Switzerland
[2] Univ Zurich Hosp, CH-8091 Zurich, Switzerland
[3] Univ Lausanne, Lausanne, Switzerland
来源：
CLINICAL PHARMACOLOGY & THERAPEUTICS | 2003年 / 73卷 / 02期
关键词：
D O I：
10.1016/S0009-9236(03)90613-8
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：P69 / P69
页数：1
相关论文
共 50 条
  • [11] Intracellular indinavir pharmacokinetics in HIV positive patients
    Hennessy, M
    Clarke, S
    Mulcahy, F
    Bergin, C
    Tjia, J
    Back, D
    Barry, M
    AIDS, 2000, 14 : S97 - S97
  • [12] Pharmacokinetics of nelfinavir and indinavir in HIV-1-infected pregnant women
    Kosel, BW
    Beckerman, KP
    Hayashi, S
    Homma, M
    Aweeka, FT
    AIDS, 2003, 17 (08) : 1195 - 1199
  • [13] The steady-state plasma pharmacokinetics of indinavir alone or in combination with ritonavir in twice daily dosing regimens in HIV-1 infected patients.
    van Heeswijk, RPG
    Veldkamp, AI
    Hoetelmans, RMW
    Mulder, JW
    Beijnen, JH
    Meenhorst, PL
    AIDS, 1998, 12 : S31 - S31
  • [14] Meal composition effects on the oral bioavailability of indinavir in HIV-infected patients
    Carver, PL
    Fleisher, D
    Zhou, SY
    Kaul, D
    Kazanjian, P
    Li, C
    PHARMACEUTICAL RESEARCH, 1999, 16 (05) : 718 - 724
  • [15] Meal Composition Effects on the Oral Bioavailability of Indinavir in HIV-Infected Patients
    Peggy L. Carver
    David Fleisher
    Simon Y. Zhou
    Daniel Kaul
    Powel Kazanjian
    Cheng Li
    Pharmaceutical Research, 1999, 16 : 718 - 724
  • [16] Population pharmacokinetics of nevirapine in Thai HIV-infected patients
    Wattanakul, Thanaporn
    Avihingsanon, Anchalee
    Manosuthi, Weerawat
    Punyawudho, Baralee
    ANTIVIRAL THERAPY, 2014, 19 (07) : 651 - 660
  • [17] Pharmacokinetics and pharmacodynamics of indinavir with or without low-dose ritonavir in HIV-infected Thai patients
    Burger, D
    Boyd, M
    Duncombe, C
    Felderhof, M
    Mahanontharit, A
    Ruxrungtham, K
    Ubolyam, S
    Stek, M
    Cooper, D
    Lange, J
    Phanupak, P
    Reiss, P
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2003, 51 (05) : 1231 - 1238
  • [18] Nephrolithiasis in HIV-infected patients treated with indinavir
    Rodriguez-Rosado, R
    Jimenez-Nacher, I
    Valencia, E
    Soriano, V
    Gonzalez-Lahoz, JG
    ANTIVIRAL THERAPY, 1998, 3 (02) : 113 - 113
  • [19] Indinavir urolithiasis: An emerging cause of renal colic in the HIV patients.
    Kohan, AD
    Armenakas, NA
    Fracchia, JA
    JOURNAL OF UROLOGY, 1998, 159 (05): : 177 - 177
  • [20] Low-doses of indinavir boosted with ritonavir in HIV-infected Thai patients: pharmacokinetics, efficacy and tolerability
    Cressey, TR
    Leenasirimakul, P
    Jourdain, G
    Tod, M
    Sukrakanchana, P
    Kunkeaw, S
    Puttimit, C
    Lallemant, M
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2005, 55 (06) : 1041 - 1044
12345